Dr Reddy's, Cipla invest in ABCD Technologies

Dr Reddy's, Cipla invest in ABCD Technologies

AgenciesUpdated: Thursday, April 01, 2021, 07:07 AM IST
article-image
Dr Reddy's, Cipla invest in ABCD Technologies |

Drug majors Dr Reddy's Laboratories and Cipla on Wednesday said they have entered into a partnership agreement with ABCD Technologies LLP which is to be renamed as IndoHealth Services LLP.

The two firms are contributing up to Rs 40 crore each corresponding to the contribution by the other partners in the target entity which is a newly incorporated limited liability partnership (LLP) and has not commenced any business activities, they said in regulatory filings.

The proposed business of the target entity will be carried out with an objective to facilitate the digitisation of the healthcare infrastructure in India towards enhancement of good distribution practices in support of the National Digital Health Mission of the government, they added.

While Cipla said the nature of consideration is cash infusion as capital contribution towards partnership, Dr Reddy's said the nature of consideration is cash infusion as capital contribution and/or loan.

Contribution of up to Rs 40 crore is for up to 20 per cent share of profit/ loss in the target entity, the firms said.

RECENT STORIES

Dentsu Lays Off 3,400 Employees Globally Amid Cost-Cutting Drive

Dentsu Lays Off 3,400 Employees Globally Amid Cost-Cutting Drive

Nazara Tech Shares Slide 20% In 4 Days Amid Online Gaming Bill Concerns

Nazara Tech Shares Slide 20% In 4 Days Amid Online Gaming Bill Concerns

IREDA Signs MoU With MNRE, Sets ₹8,200 Crore Revenue Target For FY 2025-26

IREDA Signs MoU With MNRE, Sets ₹8,200 Crore Revenue Target For FY 2025-26

Gold Slips ₹200 To ₹1,00,170 Per 10 Grams; Silver Trades Flat At ₹1,15,000 Per kg

Gold Slips ₹200 To ₹1,00,170 Per 10 Grams; Silver Trades Flat At ₹1,15,000 Per kg

GST Council's decision To Slash GST On Cancer Medicines, Essential Drugs ‘Commendable’: IMA

GST Council's decision To Slash GST On Cancer Medicines, Essential Drugs ‘Commendable’: IMA